Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting
A Phase 2 Randomized, Controlled, Open-label (Dose-blinded), Multi-center, Dose-finding Study of the Safety and Efficacy of I-0401 in the Treatment of Patients With Fractures of the Tibial Plateau Requiring Grafting.
1 other identifier
interventional
208
9 countries
45
Brief Summary
For certain tibial plateau fractures the bone is compressed due to the force acting on the tibia during the accident. The void provoked by the compression of the bone is filled with an appropriate filling material and the fracture is fixated. I 0401 is a new bone graft substitute that has shown capacities to promote bone-healing. This study will test the safety and efficacy of I 0401 in the treatment of patients with tibial plateau fractures requiring grafting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Nov 2006
Longer than P75 for phase_2
45 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 8, 2006
CompletedFirst Posted
Study publicly available on registry
December 11, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedMarch 16, 2012
March 1, 2012
4.8 years
December 8, 2006
March 15, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Radiographic Images
All Follow-Up Visits
Secondary Outcomes (5)
Clinical assessments of the fracture site
All Follow-Up Visits
Blood parameters
All Follow-Up Visits
Vital signs
At several Follow-Up visits
Questionnaires of Life
All Follow-Up Visits
Pharmacoeconomic evaluation
All Follow-Up Visits
Study Arms (3)
1
EXPERIMENTALExperimental - high dose
2
EXPERIMENTALExperimental - low dose
3
ACTIVE COMPARATORAutograft
Interventions
Eligibility Criteria
You may qualify if:
- Radiological evidence of a tibial plateau fracture requiring grafting
- Females of child-bearing potential must be willing to undergo a pregnancy test (urine) prior to treatment start (at screening).
You may not qualify if:
- Concomitant ipsilateral fractures of the limb other than the fracture of the tibial plateau.
- Active or past history of malignant tumor.
- Evidence of systemic or localized infection at time of surgery.
- Pregnant or lactating females.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (45)
Gold Coast Hospital (49)
Gold Coast, Queensland, 4215, Australia
Princess Alexandra Hospital (45)
Woollongabba, Queensland, 4102, Australia
Royal Adelaide Hospital (48)
Adelaide, South Australia, 5000, Australia
Hopital La Cavale Blanche (19)
Brest, 29200, France
Hôpital de Dunkerque (30)
Dunkirk, 59380, France
Hôpital Central de Nancy (05)
Nancy, 54000, France
Hôpital Charles Nicolle (15)
Rouen, 76031, France
Charite, Campus Virchow Klinikum (03)
Berlin, 13353, Germany
Berufsgenossenschaftliche Unfallklinik Bochum/Duisburg (11)
Duisburg, 47249, Germany
Uniklinik Göttingen (22)
Göttingen, 37075, Germany
Med. Hochschule Hannover (06)
Hanover, 30625, Germany
Universitätsklinikum Schleswig-Holstein (40)
Kiel, 24105, Germany
St.-Josef-Krankenhaus (12)
Linnich, 52441, Germany
Chirurgische Klinik der LMU (50)
München, 81366, Germany
Universitätsklinikum Münster (39)
Münster, 48149, Germany
Fövarosi Önkormanyzat Karolyi Sandor Korhaz es Rendelointezet (21)
Budapest, 1041, Hungary
Fövarosi Önkormanyzat Peterfy Sandor utcai Korhaz-Rendelöinezet es Baleseti Központ (20)
Budapest, 1081, Hungary
Fovárosi Önkormányzat Szent János Kórháza és Észak (54)
Budapest, 1125, Hungary
Petz Alandar County Teaching Hospital (55)
Győr, 9024, Hungary
Szegedi Egyetem AOK Kari Gyogyszertar (27)
Szeged, 6725, Hungary
Istituti Ortopedici Rizzoli (13)
Bologna, 40136, Italy
Fondazione Istituto San Raffaele G. Giglio di Cefalù (16)
Cefalù, 90015, Italy
A.O. Universitaria San Martino (33)
Genova, 16132, Italy
Università degli Studi di Roma "Tor Vergata" (10)
Roma, 00133, Italy
A.O. San Giovanni Oddolorata (14)
Roma, 00184, Italy
Klinika i Oddzial Kliniczny - Ortopedii i Traumatologii (36)
Krakow, 31-826, Poland
Oddzial Chirurgii Ortopedyczno-Urazowej - Wojewodzki Szpital Specjalistyczny (58)
Lodz, 93-513, Poland
SPZOZ Wojewodzki - Specjalistyczny Szpital Chirurgii Urazowej (35)
Piekary Śląskie, 41940, Poland
Katedra i Klinika Ortopedii - Traumatologii PAM (34)
Szczecin, 71252, Poland
Wojskowy Instytut Medyczny - Centralny Szpital Kliniczny MON (60)
Warsaw, 00-909, Poland
Katedra I Klinika Ortopedii AM (29)
Warsaw, 02005, Poland
Hospital Universitario de la Princesa (18)
Madrid, 28006, Spain
Hospital FREMAP Majadahonda (17)
Madrid, 28220, Spain
Hospital Universitario Virgen de la Victoria (51)
Málaga, 29010, Spain
Hospital FREMAP Sevilla (32)
Seville, 41012, Spain
Hospital Universitario La Fe (07)
Valencia, 46009, Spain
Zurich University Hospital (01)
Zurich, Canton Zurich, 8091, Switzerland
Universitätsspital Basel (24)
Basel, 4031, Switzerland
Kantonsspital Bruderholz (25)
Bruderholz, 4101, Switzerland
CHUV Lausanne (02)
Lausanne, 1011, Switzerland
Kantonsspital Luzern (26)
Lucerne, 6000, Switzerland
Leeds General Infirmary (04)
Leeds, West Yorkshire, LS1 3EX, United Kingdom
N. Bristol NHS Trust + Univ. of Bristol (52)
Bristol, BS16 1LE, United Kingdom
University Hospital of Wales (31)
Cardiff, CF14 4XW, United Kingdom
Norfolk and Norwich University Hospital (44)
Norwich, NR4 7UY, United Kingdom
Related Publications (1)
Smith TO, Casey L, McNamara IR, Hing CB. Surgical fixation methods for tibial plateau fractures. Cochrane Database Syst Rev. 2024 Aug 22;8(8):CD009679. doi: 10.1002/14651858.CD009679.pub3.
PMID: 39171616DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Messmer, MD
Zurich University Hospital, Zurich, Switzerland
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2006
First Posted
December 11, 2006
Study Start
November 1, 2006
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
March 16, 2012
Record last verified: 2012-03